tiprankstipranks
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
TipRanksTV
New
STOCKS
BABA
AAPL
NIO
AMZN
AMC
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Smart Score Stocks
Analysts' Hot Stocks
Insiders' Hot Stocks
Popular
Trending Stocks
Fastest Growing Websites
New
Penny Stocks
U.S. Markets
Market Movers
Expert Center
My Experts
Top Firms
Top Wall Street Analysts
Top Financial Bloggers
Top Corporate Insiders
Popular
Top Hedge Fund Managers
Top Individual Investors
Stock Screener
Stock Comparison
Dividend Calculator
Popular
Dividend Yield Calculator
New
Daily Stock Ratings
Daily Insider Transactions
Stock ComparisonPOPULAR COMPARISONS
WallStreetBets Stocks
NFT Stocks
EV Stocks
Crypto Stocks
Dividend Stocks
Overview
My Holdings
My Performance
My Portfolio Analysis
Crowd Insights
Earnings Calendar
Dividend Calendar
Economic Calendar
New
IPO Calendar
Stock Market Holidays
Market News
Stock Analysis & Ideas
Popular
Expert Spotlight
Tipranks Labs
Earnings Reports Insights
Pre-Market Breakdowns
Dividend Stock News
Crypto Stocks
About TipRanks
For Business
Become an Affiliate
Education Center
Reviews
Contact Us
US English
UK English
CA English
AU English
Plans & Pricing
Tarsus Pharmaceuticals (TARS)
NASDAQ:TARS
US Market
TARSnasdaq
United States
Tarsus Pharmaceuticals
Stock Analysis
Analyst Forecasts
Insider Trading
News & Insights
Crowd Wisdom
Earnings
Dividends
Financials
Similar Stocks
Charts
Risk Analysis
Hedge Funds
Blogger Opinion
reports

Tarsus Pharmaceuticals Stock News & Insights

65 Followers
Tarsus to Present Saturn-2 Pivotal Phase 3 Trial Data and Saturn-1 Extension Study Long-Term Safety Data Evaluating TP-03 for the Treatment of Demodex Blepharitis at Upcoming Eye Care Meetings
Press ReleasesTarsus to Present Saturn-2 Pivotal Phase 3 Trial Data and Saturn-1 Extension Study Long-Term Safety Data Evaluating TP-03 for the Treatment of Demodex Blepharitis at Upcoming Eye Care Meetings
1h ago
TARS
Positive data to be presented at WCC VIII and AAO 2022 conferences in Chicago ...Read more

TARS News on the Web

Should You Sell Tarsus Pharmaceuticals Inc (TARS) in Biotechnology Industry?
Investors Observer
Neutral
The Chief Medical Advisor & Director of Tarsus Pharmaceuticals, Inc. , Elizabeth Lin, Just Bought A Few More Shares
Yahoo Finance
Neutral
H.C. Wainwright Sticks to Their Buy Rating for Tarsus Pharmaceuticals (TARS)
TipRanks News
Bullish
Tarsus Submits New Drug Application to the FDA for TP-03 for the Treatment of Demodex Blepharitis
Yahoo Finance
Neutral
Should You Buy Tarsus Pharmaceuticals Inc (TARS) Stock After it Has Gained 9.37% in a Week?
Investors Observer
Neutral
How Will the Market React to Tarsus Pharmaceuticals Inc (TARS) Stock Getting a Bullish Rating
Investors Observer
Bullish
Tarsus Pharmaceuticals, Inc. (TARS) Reports Q2 Loss, Misses Revenue Estimates
Zacks
Neutral
Tarsus Pharmaceuticals, Inc. Reports Q2 Loss, Misses Revenue Estimates
Yahoo Finance
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.
Healthcare Stocks that are Trending in the News
IRTCIrhythm Technologies
CWBRCohBar
CBXCellular Goods Plc
MOHOECMOHO
LLYEli Lilly & Co
Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis
Subscribe NowSee Plans & Pricing